Abstract
mediated by changes to placental growth, rather than alterations in placental efficiency.
48

Introduction
50
Intrauterine growth restriction (IUGR) occurs when a fetus fails to achieve its genetic growth 51 potential. These fetuses have an increased risk of significant perinatal morbidity and 52 mortality, 1,2 neurodevelopmental impairment in childhood, 3 and an increased risk of adult 53 onset chronic diseases. 4 facilitating expectant management and safe pregnancy prolongation has the potential to 62 reduce dramatically both short-and long-term health and societal costs.
63
There are many causes of IUGR; however, the predominant etiology is placental 64 insufficiency, caused by a failure of placental trophoblast to adequately invade and transform 65 maternal spiral arteries in early pregnancy. [6] [7] [8] The net result of this abnormal transformation is 66 increased resistance to maternal blood flow to the placenta resulting in placental under-67 perfusion. 7, 9 In normal pregnancy, the vasodilator nitric oxide (NO) figure 1A ). The fifth centile of the control group was 3,162 g; 38% of the IUGR+V lambs 211 and 10% of the IUGR+SC group had a weight below this at post-mortem (figure 1B). The IUGR+SC group had significantly lesser proportion of placentomes weighing >4 g 231 compared to the control group (p = 0.02, Table 2 ), but the proportion of large placentomes 232 did not differ significantly from that in the controls.
233
All groups had similar proportions of A, B and C placentome types ( It is also possible that the slow subcutaneous infusion used in our experimental design did not 340 result in sufficiently high peak plasma sildenafil concentrations for maximum effect. In pregnant ewes, uterine artery embolisation resulted in reduced fetal and placental weights, 395 and an increase in fetal-placental vascular resistance (as assessed by Doppler Ultrasound).
396
These changes were all partially ameliorated when ewes were treated with sildenafil. Crown-rump length (cm) 47.8 ± 0.6 45.1 ± 1.0 
